Bangying Su

Corporate Officer/Principal presso Washington University in St. Louis

Consumer Services

Health Technology

Posizioni attive di Bangying Su

Società	Posizione	Inizio	Fine
Washington University in St. Louis	Corporate Officer/Principal	25/01/2010	-
The University of Alabama	Corporate Officer/Principal	25/01/2010	-

Società	Posizione	Inizio	Fine
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Corporate Officer/Principal	25/01/2010	-

Peking University

Undergraduate Degree

Distribuzione geografica

Stati Uniti	4
Cina	2

Posizioni

Corporate Officer/Principal	3
Undergraduate Degree	1

Settori

Consumer Services	4
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Health Technology

Aziende private

Health Technology